FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA supplemental application for Avycaz (ceftazidime/avibactam) submitted by Allergan to modify the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Bacterial Pneumonia
• Ventilator-associated Bacterial Pneumonia

Drugs mentioned

• Avycaz (ceftazidime-avibactam)

Snippet

SUPPL AP for AVYCAZ (CEFTAZIDIME, AVIBACTAM)